Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Meike H. van der Ree"'
Autor:
Elsemieke A. I. M. Meurs, Carl E. H. Siegert, Elien Uitvlugt, Najla El Morabet, Ruth J. Stoffels, Dirk W. Schölvinck, Laura F. Taverne, Pim B. J. E. Hulshof, Hilde J. S. ten Horn, Philou C. W. Noordman, Josien van Es, Nicky van der Heijde, Meike H. van der Ree, Maurice A. A. J. van den Bosch, Fatma Karapinar-Çarkit
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
Abstract Knowledge regarding preventable hospital readmissions is scarce. Our aim was to compare the clinical characteristics of potentially preventable readmissions (PPRs) with non-PPRs. Additionally, we aimed to identify risk factors for PPRs. Our
Externí odkaz:
https://doaj.org/article/6e73a49969534dbca42c675850759961
Autor:
Najla El Morabet, Meike H. van der Ree, Hilde J. S. ten Horn, Elien B. Uitvlugt, Carl E. H. Siegert, Dirk W. Schölvinck, Nicky van der Heijde, Laura F. Taverne, Philou C. W. Noordman, Ruth J. Stoffels, Fatma Karapinar-Çarkit, Maurice A. A. J. van den Bosch, Pim B. J. E. Hulshof, Elsemieke A. I. M. Meurs, Josien van Es
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
Scientific Reports
Scientific Reports
Knowledge regarding preventable hospital readmissions is scarce. Our aim was to compare the clinical characteristics of potentially preventable readmissions (PPRs) with non-PPRs. Additionally, we aimed to identify risk factors for PPRs. Our study inc
Deep sequencing identifies hepatitis B virus core protein signatures in chronic hepatitis B patients
Autor:
Matthijs R.A. Welkers, Meike H. van der Ree, Hendrik W. Reesink, K. Anton Feenstra, Louis Jansen, Neeltje A. Kootstra
Publikováno v:
Antiviral research, 158, 213-225. Elsevier
van der Ree, M H, Jansen, L, Welkers, M R A, Reesink, H W, Feenstra, K A & Kootstra, N A 2018, ' Deep sequencing identifies hepatitis B virus core protein signatures in chronic hepatitis B patients ', Antiviral research, vol. 158, pp. 213-225 . https://doi.org/10.1016/j.antiviral.2018.08.009
van der Ree, M H, Jansen, L, Welkers, M R A, Reesink, H W, Feenstra, K A & Kootstra, N A 2018, ' Deep sequencing identifies hepatitis B virus core protein signatures in chronic hepatitis B patients ', Antiviral research, vol. 158, pp. 213-225 . https://doi.org/10.1016/j.antiviral.2018.08.009
BACKGROUND: We aimed to identify HBc amino acid differences between subgroups of chronic hepatitis B (CHB) patients.METHODS: Deep sequencing of HBc was performed in samples of 89 CHB patients (42 HBeAg positive, 47 HBeAg negative). Amino acid types w
Autor:
Meike H. van der Ree, R. Bart Takkenberg, Zita Kruize, Neeltje A. Kootstra, Ad C. van Nuenen, Hendrik W. Reesink, Louis Jansen, Karel A. van Dort
Publikováno v:
Journal of Infectious Diseases, 215(9), 1421-1429. Oxford University Press
Journal of infectious diseases, 215(9), 1421-1429. Oxford University Press
Van Der Ree, M H, Jansen, L, Kruize, Z, Van Nuenen, A C, Van Dort, K A, Bart Takkenberg, R, Reesink, H W & Kootstra, N A 2017, ' Plasma MicroRNA levels are associated with Hepatitis B e antigen status and treatment response in chronic Hepatitis B patients ', Journal of Infectious Diseases, vol. 215, no. 9, pp. 1421-1429 . https://doi.org/10.1093/infdis/jix140
Journal of infectious diseases, 215(9), 1421-1429. Oxford University Press
Van Der Ree, M H, Jansen, L, Kruize, Z, Van Nuenen, A C, Van Dort, K A, Bart Takkenberg, R, Reesink, H W & Kootstra, N A 2017, ' Plasma MicroRNA levels are associated with Hepatitis B e antigen status and treatment response in chronic Hepatitis B patients ', Journal of Infectious Diseases, vol. 215, no. 9, pp. 1421-1429 . https://doi.org/10.1093/infdis/jix140
Background. Hepatitis B virus (HBV) modulates microRNA (miRNA) expression to support viral replication. The aim of this study was to identify miRNAs associated with hepatitis B e antigen (HBeAg) status and response to antiviral therapy in patients wi
Autor:
Michael Huang, Adam Pavlicek, Ad C. van Nuenen, S.B. Willemse, Neeltje A. Kootstra, J. Marleen L. de Vree, F. Stelma, Janke Schinkel, Svend Rietdijk, Salah Hadi, P. Grint, Eva van der Veer, Meike H. van der Ree, S. Neben, Kai Liu, Richard Molenkamp, Jacqueline Blem, Marc van der Valk, Amy K Patick, John Grundy, Neil W. Gibson, Marten Harbers, Ulrich Beuers, Hendrik W. Reesink
Publikováno v:
The Lancet, 389(10070), 709-717. ELSEVIER SCIENCE INC
Lancet, 389(10070), 709-717. Elsevier Limited
Lancet, 389(10070), 709-717. Elsevier Limited
Summary Background miR-122 is an important host factor for hepatitis C virus (HCV) replication. The aim of this study was to assess the safety and tolerability, pharmacokinetics, and antiviral effect of a single dose of RG-101, a hepatocyte targeted
Autor:
J. Marleen L. de Vree, Leo Swadling, Marc van der Valk, Hendrik W. Reesink, S.B. Willemse, Neeltje A. Kootstra, Paul Klenerman, Anthony Brown, M.J. Sinnige, Meike H. van der Ree, F. Stelma, Ad C. van Nuenen, Eleanor Barnes
Publikováno v:
Antiviral research, 146, 139-145. Elsevier
Antiviral Research, 146, 139-145. ELSEVIER SCIENCE BV
Antiviral research
Antiviral Research, 146, 139-145. ELSEVIER SCIENCE BV
Antiviral research
Background&aims With the introduction of DAA's, the majority of treated chronic hepatitis C patients (CHC) achieve a viral cure. The exact mechanisms by which the virus is cleared after successful therapy, is still unknown. The aim was to assess the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::100eddfe992c5853c8f87337ae3d8269
https://pure.amc.nl/en/publications/immune-responses-in-daa-treated-chronic-hepatitis-c-patients-with-and-without-prior-rg101-dosing(f3f7eef2-d623-411e-b101-c9c0a8b012a8).html
https://pure.amc.nl/en/publications/immune-responses-in-daa-treated-chronic-hepatitis-c-patients-with-and-without-prior-rg101-dosing(f3f7eef2-d623-411e-b101-c9c0a8b012a8).html
Autor:
Arend F. Bos, Anna E. Huis in ‘t Veld, Koenraad N.J.A. Van Braeckel, Paul P. van den Berg, Elise Roze, Jozien C. Tanis, Meike H van der Ree
Publikováno v:
Pediatric Research, 72(6), 641-648. Nature Publishing Group
Our aim was to determine functional outcome of very preterm-born and small-for-gestational-age (SGA) children as compared with matched controls at school age.We included 28 very preterm SGA children (GA32 wk, birth weight (BW)10th percentile), born i
Autor:
Femke, Stelma, Meike H, van der Ree, Marjan J, Sinnige, Anthony, Brown, Leo, Swadling, J Marleen L, de Vree, Sophie B, Willemse, Marc, van der Valk, Paul, Grint, Steven, Neben, Paul, Klenerman, Eleanor, Barnes, Neeltje A, Kootstra, Hendrik W, Reesink
Publikováno v:
Hepatology (Baltimore, Md.). 66(1)
MicroRNA-122 is an important host factor for the hepatitis C virus (HCV). Treatment with RG-101, an N-acetylgalactosamine-conjugated anti-microRNA-122 oligonucleotide, resulted in a significant viral load reduction in patients with chronic HCV infect
Publikováno v:
Early Human Development, 87(12), 821-826. ELSEVIER IRELAND LTD
BackgroundLate-onset sepsis is a relatively common complication particularly of preterm birth that affects approximately a quarter of very low birth weight infants.AimWe aimed to determine the motor, cognitive, and behavioural outcome at school age o
Autor:
Peter L.M. Jansen, Joep de Bruijne, Meike H. van der Ree, Neeltje A. Kootstra, Hendrik W. Reesink
Publikováno v:
Antiviral therapy. 19(6)
MicroRNAs regulate gene expression by binding to the 3‘-untranslated region (UTR) of target messenger RNAs (mRNAs). The importance of microRNAs has been shown for several liver diseases, for example, viral hepatitis. Micro-RNA-122 is highly abundan